Quick Answer
SELLAS Life Sciences Group, Inc. reported Cash And Cash Equivalents At Carrying Value of $71.79 million for the year ending 2025.
- SELLAS Life Sciences Group, Inc. showed an increase of +417.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from SELLAS Life Sciences Group, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $5.09 million | Q3 2010: $2.84 million | Q1 2011: $11.12 million | Q2 2011: $17.93 million | Q3 2011: $15.69 million | Q1 2012: $8.70 million | Q2 2012: $19.23 million | Q3 2012: $51.40 million | Q1 2013: $17.48 million | Q2 2013: $20.92 million | Q3 2013: $51.40 million | Q1 2014: $52.43 million | Q2 2014: $39.16 million | Q3 2014: $24.65 million | Q1 2015: $52.86 million | Q2 2015: $45.28 million | Q3 2015: $34.71 million | Q1 2016: $34.71 million | Q2 2016: $19.59 million | Q3 2016: $24.51 million | Q1 2017: $18.10 million | Q2 2017: $18.07 million | Q3 2017: $12.91 million | Q1 2018: $3.47 million | Q2 2018: $1.35 million | Q3 2018: $9.97 million | Q1 2019: $2.58 million | Q2 2019: $12.75 million | Q3 2019: $9.12 million | Q1 2020: $6.75 million | Q2 2020: $3.34 million | Q3 2020: $8.20 million | Q1 2021: $28.03 million | Q2 2021: $29.92 million | Q3 2021: $26.28 million | Q1 2022: $14.25 million | Q2 2022: $26.99 million | Q3 2022: $21.35 million | Q1 2023: $23.90 million | Q2 2023: $13.81 million | Q3 2023: $3.97 million | Q1 2024: $18.42 million | Q2 2024: $9.15 million | Q3 2024: $21.03 million | Q1 2025: $28.40 million | Q2 2025: $25.30 million | Q3 2025: $44.32 million.
- Over the full 17 years of available data (2009 to 2025), SELLAS Life Sciences Group, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,163.1%.
- Historical annual values: Fiscal year 2025: $71.79 million | Fiscal year 2024: $13.89 million | Fiscal year 2023: $2.53 million | Fiscal year 2022: $17.13 million | Fiscal year 2021: $21.36 million | Fiscal year 2020: $35.30 million | Fiscal year 2019: $7.28 million | Fiscal year 2018: $5.34 million | Fiscal year 2017: $2.32 million | Fiscal year 2016: $5.96 million | Fiscal year 2015: $1.40 million | Fiscal year 2014: $23.65 million | Fiscal year 2013: $47.79 million | Fiscal year 2012: $32.81 million | Fiscal year 2011: $47.79 million | Fiscal year 2010: $6.89 million | Fiscal year 2009: $5.68 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: